CEPTON Strategies Strategy consulting firm
Our expertise: Pharmaceuticals & Biotechnology, Medtech & Diagnostics, Healthcare Services
CEPTON is a strategy consulting boutique operating on a global scale. From strategy consulting to complex transactions, we focus on a limited number of industries facilitating a reliable and comprehensive service to develop your business. We provide innovative solutions to match these constantly evolving markets and can facilitate your expansion to new markets.
Regardless of the nature of our collaboration, our value remains the same: specialised industry experience, confidentiality, and flexibility throughout assignments.
We provide bespoke solutions to your specific requirements and are equipped to consult on general management issues or more specific challenges including:
- Strategy formulation and implementation
- Organisational structure and change management
- Company growth and performance optimisation
- Transactions and market valuations.
CEPTON has a range of proven methodologies and patented tools to help unlock your challenges.
Pharmaceuticals & Biotechnology
Medtech & Diagnostics
Discover our most recent position papers
CEPTON has published many articles in the field of healthcare and pharmaceuticals, and our partners are frequently intervied by press within our industry sectors.
Cepton amongst the leading healthcare and pharma consulting firms according to the magazine "Les décideurs"
Posted on 04.02.2020 by Marine Mousseaux
AI in drug discovery: will tomorrow’s New Molecule Entities be discovered by robots?
Posted on 02.09.2019 by Maxime Huerre
The growing role of Real-World Evidence, from regulatory strategies to patient management
Posted on 30.04.2019 by Maxime Huerre
Forever young: how the cult of beauty created a $11bn medical aesthetics market
Posted on 22.01.2019 by Maxime Huerre
CEPTON ranked among the top consulting firms in Healthcare and Pharma Industry by the magazine "Les Décideurs"
Posted on 21.01.2019 by Maxime Huerre
Radiopharmaceuticals: the crucial role of production and supply chain
Posted on 02.11.2018 by Marc-Olivier Bévierre